Azacitidine,Venetoclax
roche,Abbvie
['mds', 'leusm']
congress | #ash22
richard little, , explains the goals of myelomatch are to improve phase iii trials, and create a resource of information on drug sensitivity and clonal evolution.
#leusm #mdssm
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm